NeuroPace (NASDAQ:NPCE) Given New $16.00 Price Target at Wells Fargo & Company

NeuroPace (NASDAQ:NPCE – Get Free Report) had its target price hoisted by Wells Fargo & Company from $9.00 to $16.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective indicates a potential upside of 1.14% from the company’s […]

Related Keywords

United States ,Leerink Partnrs ,Martha Morrell ,Geode Capital Management ,Jpmorgan Chase Co ,Barclays Plc ,Neuropace Inc ,Wells Fargo Company ,Morgan Stanley ,Citigroup Inc ,Cantor Fitzgerald ,Susquehanna International Group ,Renaissance Technologies ,Get Free Report ,Wells Fargo ,International Group ,Capital Management ,Neuropace Daily ,Neuropace ,Nasdaq Npce ,Npce ,Medical ,Boost Price Target ,